Search

everythinglearnresearchcommunity

for

Search:↓

Different types of alopecia cause hair loss due to immune system issues, with some allowing regrowth and others causing permanent loss.

Alopecia areata may be treated by restoring hair follicle immune privilege and adjusting immune responses.

Hair follicle development and microbes help regulatory T cells gather in newborn skin.

Enhancing CD8+ T cell function to induce ferroptosis in tumor cells may help treat skin melanoma.

SADBE treatment led to complete hair regrowth in mice with alopecia areata by altering immune cell movement.

Special cells can help regrow hair in alopecia areata.

Alopecia areata and vitiligo share immune system dysfunction but differ in specific immune responses and affected areas.

Skin-resident memory T cells may contribute to chronic alopecia areata and baricitinib could be a potential treatment.

2-deoxy D-glucose does not help with hair regrowth in alopecia areata.

RIPK1 inhibitors may help prevent alopecia areata by reducing immune cell activity.

RXRa is crucial for Th2 immune cell development and may link nutrition to immune health.

Regulatory T cells help heal skin and grow hair, and their absence can lead to healing issues and hair loss.

Gamma/delta T cells help defend skin against heavy metals.

Regulatory T cells and mesenchymal stem cells work together to prevent immune system overreactions and tissue damage.

In alopecia areata, certain immune cells increase and express a protein linked to immune activation.

The review suggests that other immune cells besides CD8+ T cells may contribute to alopecia areata and that targeting regulatory cell defects could improve treatment.

Mesenchymal stem cells may effectively treat and prevent allergic skin conditions.

Stress increases nerve fibers and immune cell activity in mouse skin, possibly worsening skin conditions.

A gene mutation in mice causes increased mast cells and disorganized hair follicles in their skin.

BST2 protein and certain T cells increase in early alopecia areata.

Small extracellular vesicles can help diagnose and manage sepsis.

New treatments and strategies are needed for Alopecia Areata, focusing on immune response and better trial designs.

New therapies and trials are needed for Merkel cell carcinoma, a tough skin cancer.

IFNγ-primed MSC secretomes can improve joint health by reducing inflammation and supporting tissue repair.

Stem cell therapies show promise for hair regrowth in alopecia areata but need more research for safety and effectiveness.

Composite biomaterials can precisely control immune responses for better disease treatment.

Significant progress and collaborations in stem cell research and regenerative medicine were made, including advancements in hair growth, cancer therapies, and treatments for neurological disorders.

Ebastine may promote hair regrowth by increasing cell growth through the ERK pathway.

Single-cell transcriptomics helps improve animal health and productivity by studying gene expression in individual cells.

Matriptase is crucial for skin barrier, hair growth, and may contribute to skin cancer.